Hangzhou Tigermed Consulting Co (FRA:5HZ1) EPS (Basic): €0.11 (TTM As of Mar. 2026)


FRA:5HZ1 Hangzhou Tigermed Consulting Co Ltd FRA:5HZ1
86 GF Score
Price €3.68
GF Value €5.20
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hangzhou Tigermed Consulting Co EPS (Basic)?

Hangzhou Tigermed Consulting Co FRA:5HZ1 +7.60% 86 EPS (Basic) is €0.11 as of Mar. 2026. GuruFocus rates FRA:5HZ1 with a GF Score™ of 86/100 and a GF Value™ of €5.20 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Hangzhou Tigermed Consulting Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.11.

Hangzhou Tigermed Consulting Co's EPS (Diluted) for the three months ended in Mar. 2026 was €0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.11.

Hangzhou Tigermed Consulting Co's EPS without NRI for the three months ended in Mar. 2026 was €-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.07.

During the past 12 months, Hangzhou Tigermed Consulting Co's average EPS without NRIGrowth Rate was -30.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was -38.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -13.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Hangzhou Tigermed Consulting Co's highest 3-Year average EPS without NRI Growth Rate was 80.20% per year. The lowest was -38.20% per year. And the median was 26.60% per year.

Hangzhou Tigermed Consulting Co  (FRA:5HZ1) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hangzhou Tigermed Consulting Co EPS (Basic) Related Terms

Hangzhou Tigermed Consulting Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Hangzhou Tigermed Consulting Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co EPS (Basic) Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.31 0.30 0.06 0.13

Hangzhou Tigermed Consulting Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.09 -0.02 0.01
FRA:5HZ1
86GF Score
Hangzhou Tigermed Consulting Co Ltd FRA:5HZ1
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Tigermed Consulting Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hangzhou Tigermed Consulting Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(107.658-0)/853.740
=0.13

Hangzhou Tigermed Consulting Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(6.155-0)/817.385
=0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €0.11 mean?
Hangzhou Tigermed Consulting Co (FRA:5HZ1) has a EPS (Basic) of €0.11 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Hangzhou Tigermed Consulting Co and its competitors.
Is Hangzhou Tigermed Consulting Co's EPS (Basic) too high?
Hangzhou Tigermed Consulting Co's current EPS (Basic) is €0.11. Overall, Hangzhou Tigermed Consulting Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Tigermed Consulting Co's EPS (Basic) compare to TMO and DHR?
Hangzhou Tigermed Consulting Co's EPS (Basic) of €0.11 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Hangzhou Tigermed Consulting Co and its competitors. Hangzhou Tigermed Consulting Co's current EPS (Basic) is €0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Tigermed Consulting Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co (FRA:5HZ1) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.20, compared to a current price of €3.68 — trading 29.2% below its estimated fair value. The current EPS (Basic) is €0.11. Hangzhou Tigermed Consulting Co's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Hangzhou Tigermed Consulting Co (FRA:5HZ1), the current EPS (Basic) is €0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hangzhou Tigermed Consulting Co (FRA:5HZ1) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co stock appears to be undervalued. The current stock price of €3.68 is trading 29.2% below its estimated GF Value™ of €5.20. GuruFocus considers Hangzhou Tigermed Consulting Co to be Modestly Undervalued.

Key valuation signals for FRA:5HZ1:

  • EPS (Basic): €0.11
  • GF Value™: €5.20 vs. price of €3.68 (29.2% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the FRA:5HZ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hangzhou Tigermed Consulting Co Business Description

Other Exchanges 03347:Hong Kong300347:China
Address No. 508 Lujiatan Street, Room 601-610, 6th Floor, Puyan Sub-District, Binjiang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
86GF Score

Get the complete analysis for FRA:5HZ1

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.68
Price
€5.20
GF Value